Targeted chemotherapy overcomes drug resistance in melanoma is a research paper published in Genes & Development (2020). On theSindex it has a DataRank of 0.546. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.546
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWO
Grant: 1S08316N
Sylvester Comprehensive Cancer Center
Grant: R01 GM078455
Sylvester Comprehensive Cancer Center
Grant: R01 GM105754
Sylvester Comprehensive Cancer Center
Grant: DP1 CA228041
National Institutes of Health
Grant: P30CA240139
National Institutes of Health
Grant: 5DP1CA228041-03
Enhancer RNA Therapy
National Institutes of Health
Grant: 5R01GM078455-07
Elucidation of Integrator's Function
National Institutes of Health
Grant: 5R01GM105754-03
Non-coding RNAs in Transcription and Chromatin Architecture
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells
Additional file 1 of The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells